Nebulized prostacyclin (PGI2) in acute respiratory distress syndrome: impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response.
about
Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS)Clinical developments for treating ARDS.The role of inhaled prostacyclin in treating acute respiratory distress syndrome.Pharmacotherapy of acute respiratory distress syndrome.The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysisRetrospective evaluation of inhaled prostaglandins in patients with acute respiratory distress syndrome.Evolution of treatments for patients with acute lung injury.Arterial pulmonary hypertension in noncardiac intensive care unit.Nonventilatory interventions in the acute respiratory distress syndrome.The management of acute pulmonary arterial hypertension.Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults.Efficacy, safety, and medication errors associated with the use of inhaled epoprostenol for adults with acute respiratory distress syndrome: a pilot study.A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndrome.Aerosolized prostacyclins for acute respiratory distress syndrome (ARDS).Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
P2860
Q24236378-4077F8E8-1B7B-44A3-8BDB-FCD11B90ABE9Q34481953-E7D53771-3659-498B-8D22-F0597712B20FQ34490411-74DB77CD-3FAD-4AD9-81BF-40C3461FDBA3Q34706893-720B8B79-C761-4488-A0A0-FEFBB5B4C299Q35572093-4847BF5A-BDEE-4F63-9743-A469EA38C2ACQ36070920-54BC92CF-3748-4F73-96C3-D555D76B22E1Q36145843-B55EEE72-8E05-4FB4-A606-1A1B916807DDQ37019853-A84FE999-D67C-4513-AD3F-33DAC5C07722Q37071344-CDBD5622-C520-4ABC-AD5B-E4EFF2A745B2Q37766261-F97FA398-8006-4482-B6E2-88A8713AB012Q37767429-D342684F-7091-4F46-A4D2-EF18F08BABDAQ38105189-A7624928-5340-4FDC-83E9-08D6698669F5Q38204749-C464CA34-3C21-4D66-9ABC-4DA3F3097164Q38625767-CAA8DEB2-1129-4D0C-93E1-B3F27BECC629Q46695032-97F47C49-11C0-44B2-80B5-327C02B58E4F
P2860
Nebulized prostacyclin (PGI2) in acute respiratory distress syndrome: impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Nebulized prostacyclin (PGI2) ...... ease on gas exchange response.
@ast
Nebulized prostacyclin (PGI2) ...... ease on gas exchange response.
@en
type
label
Nebulized prostacyclin (PGI2) ...... ease on gas exchange response.
@ast
Nebulized prostacyclin (PGI2) ...... ease on gas exchange response.
@en
prefLabel
Nebulized prostacyclin (PGI2) ...... ease on gas exchange response.
@ast
Nebulized prostacyclin (PGI2) ...... ease on gas exchange response.
@en
P2093
P1476
Nebulized prostacyclin (PGI2) ...... ease on gas exchange response.
@en
P2093
Domenighetti G
Stricker H
Waldispuehl B
P356
10.1097/00003246-200101000-00015
P407
P577
2001-01-01T00:00:00Z